CHIMÄRE GERINNUNGSFAKTOREN

Patent europeic · EP2591099 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2591099
Numer da la dumonda
EP11738538
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-07-2011
Publitgà
15-05-2013
Concedì
18-11-2020
Stritgà
23-02-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 9/96 (2006.01)
A61K 38/48 (2006.01)
A61K 38/36 (2006.01)
Prioritad
US 201161442055 P 11.02.2011
US 201161467880 P 25.03.2011
US 363183 P 09.07.2010
US 201161491762 P 31.05.2011
US 201161442150 P 11.02.2011
US 363186 P 09.07.2010
US 201161442029 P 11.02.2011
Dumonda PCT
PCT/US2011/043597 11.07.2011
Publicaziun PCT
WO2012/006633 12.01.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-02-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.02.2022

  2. 29-09-2021

    Midada

    Published in Swissreg on 29.09.2021

  3. 18-11-2020

    Concedì

    Published in Swissreg on 18.11.2020

Partidas

Possessur

Bioverativ Therapeutics Inc.

225 Second Avenue, Waltham, MA 02451, US

Inventur

PETERS, Robert

West Roxbury MA 02132, US

SALAS, Joe

Wayland MA 01778, US

BITONTI, Alan

Acton MA 01720, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.